Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Value Stock, Under Radar

662.2500 23.80 (3.73%)

NSE May 12, 2025 12:36 PM

60.46% Fall from 52W High

Volume: 257.9K

Strides Pharma Science Ltd.

06 Sep 2024

662.25

3.73%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300mg and 450mg

More from Strides Pharma Science Ltd.

Recommended

Market trades higher, Birla Corp's Q4 revenue beats Forecaster estimates by 7.6%

Trendlyne Marketwatch | 12 May 2025, 12:28PM

Five Interesting Stocks Today - May 09, 2025

The Baseline | 09 May 2025

Earnings Call Transcript - Q1FY21 for Strides Pharma Science